Despite today’s dip, the stock has risen 43.66% in the past three months and 28.26% over six months. On a one-year basis, however, the scrip remains down 7.55%.
Shalby operates 11 multispecialty tertiary hospitals and 5 orthopedic centers under the Shalby Orthopedics Center of Excellence (SOCE) across India, with a total capacity of over 2,200 beds. The company has also diversified into knee and hip implant manufacturing in the US.
On a consolidated basis, net profit of Shalby declined 43.04% to Rs 8.92 crore while net sales rose 6.29% to Rs 296.43 crore in Q1 June 2025 over Q1 June 2024.